In experiments using CT‐26/EV cells that are not forced to overexpress KITENIN, tumour growth in the KDIP‐treated group showed a tendency to be slightly reduced at 2 weeks after injection, compared with those of vehicle‐treated or scramble peptide‐treated group (Figure S8C). Here, VANGL1 is linked to neoplasm.